About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Immunicum image

Immunicum

Summary
History
Mission
Vision
References
Summaryarrow
Immunicum is a clinical-stage biopharmaceutical company developing a unique approach to activate the body’s own ability to fight cancer.
Historyarrow

Immunicum was founded in 2007 by scientists and clinicians from the University of Gothenburg and Sahlgrenska University Hospital and was later joined by InnovationsKapital AB and Impilo AB. In 2014, Immunicum branched off into a separate and publicly tradable entity. After the IPO, Immunicum had its first full year in operation, closing the list of activities in the 2015 financial year with a net result of MSEK -25.9.

Missionarrow
Immunicum’s mission is to develop safe and effective treatments for cancer patients by capitalizing on the powerful anti-tumor responses harnessed by its unique immunomodulatory approach.
Visionarrow
Immunicum’s vision is to become a global leader in translational oncology by providing novel and effective immuno-oncology drugs for patients with advanced cancers, and for patients where the current standard therapies have failed.
Referencesarrow

https://in.investing.com/equities/immunicum-ab-company-profile

https://finance.yahoo.com/quote/SE0005003654.SG/profile?p=SE0005003654.SG

https://www.crunchbase.com/organization/immunicum-ab

immunicum.se/

Share

Leadership team
A
Alex Karlsson- Parra (Founder)
Products / Services
Biotechnology, Clinical Trials, Therapeutics
Number of Employees
0 - 50
Address
Gothenburg, Vastra Gotaland, Sweden
Established
2002-01-01
Company Registration
SEC CIK number: 0000722830
Traded as
STO:IMMU
Website
immunicum.se/
Social Media
linkedinx
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo